Cargando…
Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy
Increasing evidences show that unmodified extracellular vesicles (EVs) derived from various cells can effectively inhibit the malignant progression of different types of tumors by delivering the bioactive molecules. Therefore, EVs are expected to be developed as emerging anticancer drugs. Meanwhile,...
Autores principales: | Wu, Manling, Wang, Min, Jia, Haoyuan, Wu, Peipei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347476/ https://www.ncbi.nlm.nih.gov/pubmed/35915054 http://dx.doi.org/10.1080/10717544.2022.2104404 |
Ejemplares similares
-
Emerging Roles of Using Small Extracellular Vesicles as an Anti-Cancer Drug
por: Joo, Hyeon Su, et al.
Publicado: (2023) -
Exosomes and Extracellular Vesicles as Emerging Theranostic Platforms in Cancer Research
por: Ailuno, Giorgia, et al.
Publicado: (2020) -
Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy
por: Liu, Xinyi, et al.
Publicado: (2023) -
Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy
por: Ma, Yifan, et al.
Publicado: (2021) -
The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer
por: Soekmadji, Carolina, et al.
Publicado: (2015)